Palbociclib and INCMGA00012 in People With Advanced Liposarcoma
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The researchers are doing this study to find out whether combining the study drugs
palbociclib and INCMGA00012 is an effective and safe treatment for advanced liposarcoma.